NMRA

Neumora Therapeutics, Inc.

1.31 USD

Last updated Sep 4, 20:04 UTC

Yesterday HIGH

$1.39

Yesterday LOW

$1.34

52w HIGH

$3.65

52w LOW

$0.83

EPS

-0.23

PE

-5.70

Next Earnings

Nov 5, 2026

Overview News Government Trades Fundamentals

Neumora Therapeutics, Inc. stock is down -18.63% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 3 September’s closed higher than August.

Avi Kapoor

Mon Jun 15, 2026

Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June

US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial production up 0.1%. Housing market index declines to 35.
Benzinga Newsdesk

Mon Jun 15, 2026

Neumora Therapeutics shares are trading lower after the company announced Navacaprant did not achieve the primary endpoint in KOASTAL-2 or -3 and the company discontinued its development.
Avi Kapoor

Mon Jun 15, 2026

Dow Jumps Over 600 Points Following US-Iran Peace Deal

US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks down. Trump announces deal, oil futures decline.
Benzinga Newsdesk

Mon Jun 15, 2026

Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk

Mon Jun 15, 2026

Neumora Therapeutics Says Navacaprant Did Not Achieve Primary Endpoint In KOASTAL-2 Or -3; Company To Discontinue Development Of Navacaprant

Neumora Therapeutics, Inc. (NASDAQ:NMRA) a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent
Benzinga Newsdesk

Mon Jun 15, 2026

Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk

Fri May 8, 2026

'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive

Health officials explored restricting specific antidepressants among SSRI drugs-sources
Benzinga Newsdesk

Thu May 7, 2026

Neumora Therapeutics shares are trading lower. The company reported its Q1 financial results.
Benzinga Newsdesk

Thu May 7, 2026

Neumora Therapeutics Q1 EPS $(0.30) Beats $(0.33) Estimate

Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 28.57 percent increase over losses of $(0.42) per share
Avi Kapoor

Mon Apr 27, 2026

Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures mixed with Dow futures down 0.1%. Domino's Pizza misses earnings expectations, shares fall 3.8%. Other stocks also decline.

SNOW $337.78 USD

ALAB $312.28 USD

LHX $256.46 USD

BITX BITX $18.24 USD

LLY $1,143.03 USD

SNDK $1,723.40 USD

TWST $124.44 USD

IREN $44.28 USD

LULU $100.45 USD

ASML $1,708.74 USD